# The Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2024, Regulation 25: Amendment of regulation 175


(1) Regulation 175 (offences relating to exceptions) is amended as follows.
(2) In paragraph (3)—
(a) in sub-paragraph (a), replace “or 170(1) (records in connection with special medicinal products etc)” with “, 170(1) (records in connection with special medicinal products etc), 170A(1) (MM medicinal products: pharmacovigilance requirements), or 170B(1) (POC medicinal products: pharmacovigilance requirements)”;
(b) in sub-paragraph (b), replace “or 170(2)” with “, 170(2), 170A(3) or 170B(3)”; and
(c) in sub-paragraph (c), after “170(3)” insert “, 170A(4) or 170B(4)”.

---
Source: https://www.legislation.gov.uk/ukdsi/2024/9780348264579/regulation/25 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-modular-manufacture-and-point-of-care-regulations-2024/regulation-25
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

